The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Research Report 2025

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1885945

No of Pages : 99

Ask Your Query
Synopsis
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global Point-of-Care Infectious Disease Diagnostics & Testing market was valued at US$ 2053.6 million in 2023 and is anticipated to reach US$ 2764.3 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Infectious Disease Diagnostics & Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Infectious Disease Diagnostics & Testing.
Report Scope
The Point-of-Care Infectious Disease Diagnostics & Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Infectious Disease Diagnostics & Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-Care Infectious Disease Diagnostics & Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Segment by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Segment by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-Care Infectious Disease Diagnostics & Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Perspective (2019-2030)
2.2 Point-of-Care Infectious Disease Diagnostics & Testing Growth Trends by Region
2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Region (2019-2024)
2.2.3 Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2025-2030)
2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
2.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
2.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
2.3.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue (2019-2024)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics & Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2023
3.5 Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Type (2019-2024)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2025-2030)
5 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Application (2019-2024)
5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2019-2030)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
6.4 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2019-2030)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
7.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2019-2030)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2019-2030)
9.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
9.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2019-2030)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Detail
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.3.4 Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Detail
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Detail
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Detail
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Detail
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Detail
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Detail
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Detail
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
11.12.1 Sight Diagnostics Ltd. Company Detail
11.12.2 Sight Diagnostics Ltd. Business Overview
11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
11.13.1 Gene POC Company Detail
11.13.2 Gene POC Business Overview
11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Detail
11.14.2 Trivitron Healthcare Business Overview
11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
11.15.1 OJ-Bio Ltd. Company Detail
11.15.2 OJ-Bio Ltd. Business Overview
11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Detail
11.16.2 Ortho-Clinical Diagnostics Business Overview
11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2019-2024)
11.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock